Efficacy and safety of N-acetyl-L-leucine in Niemann-Pick disease type C.

J Neurol · 2022 · PMC8361244 · PMID 34387740

Europe PMC DOI

hedged sentence

0.0840

closest p · 1.7× alpha

0.0840

boldest claim

The sentences

showed a trendp = 0.084so close (0.05 < p ≤ 0.1)

The score during the treatment period showed a trend towards improvement, with a mean change (Visit 2 to Visit 4) of 0.0995 (SD = 0.3058, median = 0.0890, n = 30) with 90% CI (− 0.0123, 0.1777) p = 0.084.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.